Tag: entrepreneurs
-
University Prof to Commercialize 3-D Printed Cell Platforms
15 December 2014. A biomedical engineer at Louisiana Tech University in Ruston plans to develop a commercial platform for three-dimensional printing of artificial cells in research, education, and industrial applications. Mark DeCoster, an engineering faculty member at Louisiana Tech, received a $50,000 National Science Foundation I-Corps grant to further develop the idea into a marketable…
-
Nanomedicine Developer Secures $7.5M Venture Funds
15 December 2014. Cristal Therapeutics, a developer of medications formulated as nanoscale particles, raised more than €6 million ($7.5 million) in early-stage venture funds. The financing round for the company, based in Maastricht, The Netherlands, was led by Chemelot Ventures, with current seed investors Thuja Capital, BioGeneration Ventures, Nedermaas, Utrecht University Holding, and Beheer Innovatiefonds…
-
Pfizer, Biotech Partner on Hemophilia B Gene Therapy
8 December 2014. Spark Therapeutics, a biotechnology firm in Philadelphia, is collaborating with the pharmaceutical company Pfizer to commercialize Spark’s gene therapy technology as a treatment for hemophilia B. Spark Therapeutics can gain as much as $280 million in the deal that involves sharing worldwide rights to Spark’s technology for hemophilia B with Pfizer. Hemophilia…
-
Patent Awarded for Macular Degeneration Eyedrop Technology
4 December 2014. SciFluor Life Sciences LLC, a biopharmaceutical company in Cambridge, Massachusetts received a patent on a fluoride formulation for treating diseases of the retina with eyedrops rather than injections into the eye as often required. Patent 8,901,144 was awarded on 2 December by the U.S. Patent and Trademark Office to four inventors, including…
-
Cardiologists, Incubator Partner on Health Challenge
13 November 2014. American College of Cardiology is taking part in an international challenge to find start-ups developing breakthrough technologies, sponsored by 1776, an incubator and investment fund in Washington, D.C. The Challenge Cup, as the competition is called, takes place in 16 cities in 11 countries, with a total prize package of $650,000. Challenge…
-
Venture Launched to Reduce Chronic Hospitalizations
10 November 2014. Sentrian, a new enterprise in Aliso Viejo, California, announced its launch today to offer a system combining personalized remote patient monitoring and cloud-based analytics that reduces what it calls preventable hospitalizations. The company also raised $12 million in early-stage venture funds. A spin-off from Singularity University, a Silicon Valley technology training organization and…
-
High-Speed Artery Imaging Technology in Development
5 November 2014. A process to capture high-speed three-dimensional images of plaque deposits in arteries and analyze their chemical makeup for diagnosing heart conditions is being developed by Purdue University in West Lafayette, Indiana. The team from the lab of Purdue biomedical engineer and chemist Ji-Xin Cheng, with colleagues from Indiana University School of Medicine,…
-
Patent Issued for Engineered Peptides Forming Hydrogels
4 November 2014. Bioengineers at Kansas State University received a patent for their invention of a peptide, a protein-like compound, that turns into water-based gels for a number of medical applications. U.S. Patent and Trademark Office awarded patent number 8,835,395 to Xiuzhi (Susan) Sun, professor of grain science and bioengineering at Kansas State, as well…
-
Needleless Delivery Start-Up Lands $11M First-Round Funding
15 October 2014. Portal Instruments Inc., a new enterprise developing needless injections for biologic therapies and other medications, raised $11 million in its first round of venture funding. Financing for the Cambridge, Massachusetts company was led by the Sunrise division of drug maker Sanofi, venture capital company PBJ Capital, and an unnamed medical device manufacturer…
-
Cancer Therapy Biotech Raises $24M in Early Funding
14 October 2014. Raze Therapeutics, a biotechnology company designing cancer therapies that stop mechanisms feeding the growth of cancer cells, raised $24 million in its first round of venture financing. The funding round was led Atlas Venture — that co-founded Raze and provided some of its seed capital — as well as MPM Capital Management,…